SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-06
👔
Spyre Therapeutics, Inc.
@SYRE_InsiderForm 4 Filing: Turtle Cameron Sells $1.4M of $SYRE
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Spyre Therapeutics, Inc.
Ticker: $SYRE
Transaction Value
$1.4M
Price/Share: $95.51
transaction date
2026-08-03
Shares: 15,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Turtle Cameron, holds the title of Chief Executive Officer at Spyre Therapeutics, Inc..
On 2026-08-03, the insider transacted 15,000 shares.The shares were transacted at a weighted average price of $95.51 per share, resulting in a total market-relevant value of $1.4M.
Executive Summary Summary
Turtle Cameron (Chief Executive Officer) sold $1.4M of $SYRE
Post-Transaction Position: 574,583 shares
SEC Accession No: 0001636282-26-000099 (CIK: 1758363)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.